Dilip Shanghvi, chairman of India's largest drugmaker Sun Pharma, told an industry gathering last week that his company sells ...

Sun Pharmaceutical Industries Ltd. closed 14.48% below its 52-week high of 1,960.20 rupees, which the company reached on ...

Sun Pharmaceuticals Industries Ltd is quoting at Rs 1673.25, up 1.08% on the day as on 12:49 IST on the NSE. The stock is up 7.36% in last one year as compared to a 1.54% jump in NIFTY and a 8.67% ...

The country's top specialty generics company recently acquired US-based Checkpoint that will further its oncology portfolio ...

Welcome to the Sun Pharma Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a ...

Benchmark indices end mixed as BSE Sensex closes slightly lower, NSE Nifty edges up; selective buying boosts recovery amid ...

The brokerage firm Motilal Oswal had a ‘Buy call on three stocks on March 11. It has picked Sun Pharma after Checkpoint ...

Sun Pharma surges 3% on Checkpoint Therapeutics acquisition; Motilal Oswal maintains 'Buy' with 22% upside potential. Read ...

Sun Pharma share price today reached ₹1,651.80, a 2.50% rise from its last close of ₹1,611.50. The rise is despite the ...

This came to pass after a landmark acquisition of US-based biotech company Checkpoint Therapeutics. Sun Pharma acquired the Massachusetts-based company for a staggering USD 355 million or about Rs ...

Vikas Khot Sun Pharma to acquire cancer drug maker Checkpoint for $355 million. Sun Pharmaceutical Industries has agre ...

Nuvama has downgraded IndusInd Bank to "Reduce" citing concerns over internal derivative trades and management changes, while ...